Evidence map›Paper›PMID 36824383›Full record

ArticleTransgender health2023

Hormone Prescription and HIV Screening/Preventive Practices Among Clinicians Providing Care for Transgender Individuals.

Mabel Toribio, Madeline Cetlin, Evelynne S Fulda, Sarah M Chu, Jorge Gómez Tejeda Zañudo, Tonia Poteat, Karen Donelan, Markella V Zanni

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Transgender health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mabel ToribioMetabolism Unit, Division of Endocrinology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0002-4153-5568
Madeline CetlinMetabolism Unit, Division of Endocrinology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Evelynne S FuldaMetabolism Unit, Division of Endocrinology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Sarah M ChuMetabolism Unit, Division of Endocrinology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Jorge Gómez Tejeda ZañudoEli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Tonia PoteatDepartment of Social Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
Karen DonelanHealth Policy Research Center at the Mongan Institute, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Markella V ZanniMetabolism Unit, Division of Endocrinology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Funding

Research Services CoreP2CHD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN B GUZZO · 2015 to 2026
$9.6M
Cardiometabolic Effects of Gender-Affirming Hormonal Therapy among Transgender Women with HIVK23HL147799 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI TORIBIO, MABEL · 2019 to 2023
$992k
Consequences of Persistent Immune Activation among ART-treated Women with HIVK24AI157882 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI ZANNI, MARKELLA V. · 2021 to 2025
$908k
NHLBI NIH HHS K23 HL147799NIAID NIH HHS K24 AI157882NICHD NIH HHS P2C HD050924
6 · The paper itself

Abstract

Purpose: Through a survey-based approach, we sought to investigate regional differences in gender-affirming hormone therapy (GAHT) prescribing practices, as well as HIV screening and prevention practices among clinicians providing care to transgender individuals. Methods: Our survey was disseminated between December 2019 and January 2021 to clinicians who prescribe GAHT within New England (United States). Between-group differences in GAHT prescribing and HIV screening/prevention practices were evaluated by practice setting and subspecialty. Results: Of the 20 survey respondents, 55% practiced in health care settings affiliated with an academic institution, 45% practiced in a community-based health care setting, and 30% were Endocrinologists. Clinicians in community-based health care settings reported more frequently prescribing oral 17β-estradiol ( Conclusions: Regional GAHT prescribing practices varied by setting. Additional research is needed to better understand whether these differences translate to differences in GAHT efficacy and side-effects. Further, HIV screening/prevention practices varied by subspecialty. Integrated GAHT and HIV screening/prevention across subspecialties could help reduce the disproportionate burden of HIV faced by the transgender community.

Indexed as

gender-affirming hormone therapyHIVHIV preventionHIV screeningtransgender

Identifiers

PMID36824383
PMCPMC9942173

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.